PortView
BriaCell Therapeutics Corp. (BCTX) Stock Analysis
NASDAQHealthcareBiotechnology
What BriaCell Therapeutics Corp. does
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company primarily focused on developing innovative immunotherapies to combat cancer. The firm's leading experimental drug, Bria-IMT, is currently undergoing Phase I/IIa clinical investigation. This crucial study evaluates its effectiveness when utilized in conjunction with immune checkpoint inhibitors for treating breast cancer. Beyond its flagship program, BriaCell has forged a collaborative research and development partnership with the National Cancer Institute (NCI). This alliance is dedicated to progressing Bria-OTS, a personalized immunotherapy designed for advanced breast cancer patients, and BriaDx, a proprietary diagnostic assay. The company's main offices are situated in West Vancouver, Canada.
Key metrics
ETFs linked to BCTX
Broad-market and Healthcare sector ETFs an investor holding BriaCell Therapeutics Corp. is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how BCTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze BCTX in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for BriaCell Therapeutics Corp.?
- BriaCell Therapeutics Corp. trades under the ticker BCTX on NASDAQ.
- Which exchange is BCTX listed on?
- BCTX is listed on NASDAQ.
- What sector does BriaCell Therapeutics Corp. operate in?
- BriaCell Therapeutics Corp. is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze BCTX in a portfolio?
- PortView shows BCTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.